Amitoz Manhas, MD
Neurological Surgery · Spokane, WANPI 1033382866
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $308 and has fallen 82.8% since, to $53 in 2025. That places this record below the midpoint for neurological surgery clinicians in WA, where the typical reported total is $2,219.
Across 32 payments — averaging $25.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$146
- Johnson & Johnson$82
- Kls-martin L.p.$82
- UCB, Inc.$77
- Acadia Pharmaceuticals Inc$55
- Eisai Inc.$49
- plus $337 from 13 others
What the payments were for
- Food & beverage$828100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $146 |
| Johnson & Johnson | 3 | $82 |
| Kls-martin L.p. | 1 | $82 |
| UCB, Inc. | 2 | $77 |
| Acadia Pharmaceuticals Inc | 2 | $55 |
| Eisai Inc. | 2 | $49 |
| Argenx US, Inc. | 2 | $49 |
| Neurelis, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Medtronic | 2 | $30 |
| Novartis | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Tanabe Pharma America, Inc. | 1 | $24 |
| Integra Lifesciences Corporation | 1 | $20 |
| Upsher-smith Laboratories LLC | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
How this compares
$828 in reported general payments places this provider in the 30th percentile of 175 neurological surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurological surgery in Spokane
- Allan HellerSpokane$132K
- Jonathan CarlsonSpokane$20K
- Nathaniel WhitneySpokane$14K
- Rod OskouianSeattle$2.4M
- Christoph HofstetterSeattle$768K
- David YamBrush Prairie$471K
- Stephen MonteithSeattle$151K
- Jean-Christophe LevequeSeattle$120K
- Vijay YanamadalaSeattle$85K
- Hoan Vu TranSeattle$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.